Thus, PAK1 signalling through AKT and ERK pathways is dependent on the cancer type, and our study suggests that PAK1 mediates pancreatic cancer cell growth through the AKT pathway rather than the ERK pathway. This evidence concerns the gene AKT1 and familial pancreatic carcinoma.